Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dror Luger

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Seminars in Immunopathology|March 5, 2008
New perspectives on effector mechanisms in uveitisDror Luger, Rachel R Caspi
General and Comparative Endocrinology|September 13, 2002
Hyper- or hypothyroidism: its association with the development of ascites syndrome in fast-growing chickensDror Luger, Dmitri Shinder, Shlomo Yahav
Handbook of Experimental Pharmacology|April 7, 2017
Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its ImplicationsMichael J Lipinski, Dror Luger, Stephen E Epstein
Journal of Clinical Immunology|December 29, 2004
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulationDror Luger, Molly Dayan, Heidy Zinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse modelAmir Sharabi, Dror Luger, Hava Ben-David, et al.
Journal of the American College of Cardiology|April 30, 2016
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial InfarctionPeter C Westman, Michael J Lipinski, Dror Luger, et al.
Journal of Leukocyte Biology|May 23, 2008
Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cellsLizette M Cortes, Dody Avichezer, Phyllis B Silver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashionAleksandra V Rachitskaya, Anna M Hansen, Reiko Horai, et al.
Ophthalmic Research|April 19, 2008
Mouse models of experimental autoimmune uveitisRachel R Caspi, Phyllis B Silver, Dror Luger, et al.
Plos One|October 23, 2013
Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effectsDror Luger, Yu-An Yang, Asaf Raviv, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Seminars in Immunopathology|March 5, 2008
New perspectives on effector mechanisms in uveitisDror Luger, Rachel R Caspi
General and Comparative Endocrinology|September 13, 2002
Hyper- or hypothyroidism: its association with the development of ascites syndrome in fast-growing chickensDror Luger, Dmitri Shinder, Shlomo Yahav
Handbook of Experimental Pharmacology|April 7, 2017
Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its ImplicationsMichael J Lipinski, Dror Luger, Stephen E Epstein
Journal of Clinical Immunology|December 29, 2004
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulationDror Luger, Molly Dayan, Heidy Zinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse modelAmir Sharabi, Dror Luger, Hava Ben-David, et al.
Journal of the American College of Cardiology|April 30, 2016
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial InfarctionPeter C Westman, Michael J Lipinski, Dror Luger, et al.
Journal of Leukocyte Biology|May 23, 2008
Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cellsLizette M Cortes, Dody Avichezer, Phyllis B Silver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashionAleksandra V Rachitskaya, Anna M Hansen, Reiko Horai, et al.
Ophthalmic Research|April 19, 2008
Mouse models of experimental autoimmune uveitisRachel R Caspi, Phyllis B Silver, Dror Luger, et al.
Plos One|October 23, 2013
Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effectsDror Luger, Yu-An Yang, Asaf Raviv, et al.
Pageof 2